Head to head
Nicotinamide Riboside against NAD+
The most-studied oral NAD precursor against the intravenous form of the coenzyme itself. Nicotinamide riboside reliably raises blood NAD in humans and the mouse lifespan programme that tested it found no effect; the IV product has far less evidence of any kind.
Column A
Nicotinamide RibosideNicotinamide Riboside (NR)
A well-studied NAD+ precursor that reliably raises NAD+ in humans. Raising the molecule is proven; the mouse lifespan programme that tested it found no effect.
Column B
NAD+Nicotinamide Adenine Dinucleotide
A central metabolic coenzyme marketed via IV and injectable forms for anti-aging and recovery, with declining levels in aging but limited clinical proof for supplementation.
Side by side, on the facts we can check
| Attribute | Nicotinamide Riboside | NAD+ |
|---|---|---|
| Category | Longevity | Longevity |
| FDA status | Sold as a supplement; not an approved drug | Not an approved drug; marketed via compounding and supplements |
| Half-life | Short | Short |
| Molecular weight | 255.2 Da | 663.4 Da |
| Mechanism | Converts to NAD+ through the salvage pathway, restoring NAD+ that declines with age and supporting mitochondrial and repair enzymes. | Acts as an electron carrier in metabolism and as a substrate for sirtuins and PARPs; raising NAD+ is proposed to support mitochondrial function and cellular repair. |
| Human studies cited | 4 | 1 |
| Legal status, US | Sold as a dietary supplement | Not FDA-approved; compounded/IV and supplement forms marketed |
Frequently asked questions
What is the difference between Nicotinamide Riboside and NAD+?
Nicotinamide Riboside: A well-studied NAD+ precursor that reliably raises NAD+ in humans. Raising the molecule is proven; the mouse lifespan programme that tested it found no effect. NAD+: A central metabolic coenzyme marketed via IV and injectable forms for anti-aging and recovery, with declining levels in aging but limited clinical proof for supplementation.
Which has stronger research evidence, Nicotinamide Riboside or NAD+?
This database does not grade compounds. It counts what was run in people: 4 of the 5 studies cited on the Nicotinamide Riboside profile were human work, against 1 of 3 for NAD+. Those counts are of our own citation lists and understate any larger literature, and neither is a recommendation.
Are Nicotinamide Riboside and NAD+ FDA-approved?
Nicotinamide Riboside: Sold as a supplement; not an approved drug. NAD+: Not an approved drug; marketed via compounding and supplements.
Related posts
Blog articles that cover Nicotinamide Riboside or NAD+, newest first.
- Longevity / Sep 8, 2026 / 9 minThe Rapamycin Dosing Debate: What PEARL Tested, the Bioavailability Problem, and What Is Unproven
- Longevity / Sep 8, 2026 / 8 minNMN vs NR vs NAD+: The 2026 Head-to-Head Human Trials, and Who Funded the Comparisons
- Longevity / Sep 8, 2026 / 7 minSS-31 and Elamipretide: What the Forzinity Approval Does and Does Not Mean
Reviewed Sep 2026. This page sets two published records side by side. It is educational, it is not medical advice, and it contains no dosing protocols or recommendations for personal use.